Laccase of Cryptococcus neoformans Is a Cell Wall-Associated Virulence Factor

ABSTRACT Virulence is the outcome of an interaction between the host and a microbe and is characterized by a large array of opposing reactions operating at the host-pathogen interface. Cryptococcus neoformans is an important opportunistic pathogen in immunocompromised patients, including those with human immunodeficiency virus, and expresses a virulence-associated laccase which is believed to oxidize brain catecholamines and iron as a defense against host immune cells. In the present report, we investigated the cellular location of laccase to understand more fully how it contributes to cryptococcal virulence. A monoclonal antibody to the C. neoformans laccase was generated and used to show localization in the cell walls of representative serotype A (H99) and serotype D (B-3501) strains by immunoelectron microscopy. In addition, confocal microscopy was used to show a peripheral location of green fluorescent protein-tagged laccase expressed in live H99 cells. Biochemical studies showed that laccase could be released from intact cells or cell wall fractions with glucanase enzymes but was retained in the cell wall after sequential extraction with 1 M NaCl, 6 M urea, and 1% sodium dodecyl sulfate. The presence of a hydrolyzable bond linking laccase to the cell wall was suggested by removal of laccase from cell wall preparations after they were boiled in 1% sodium dodecyl sulfate, as was the presence of a disulfide or thioester bond by removal with dithiothreitol or β-mercaptoethanol. These data show that laccase is present as a tightly associated cell wall enzyme that is readily accessible for interactions with host immune cells.

[1]  A. Casadevall,et al.  Melanisation of Cryptococcus neoformans in human brain tissue , 2000, The Lancet.

[2]  A. Casadevall,et al.  Synthesis of Polymerized Melanin by Cryptococcus neoformans in Infected Rodents , 2000, Infection and Immunity.

[3]  T. Brandhorst,et al.  Cell Wall Biogenesis of Blastomyces dermatitidis , 2000, The Journal of Biological Chemistry.

[4]  A. Casadevall,et al.  Urease as a Virulence Factor in Experimental Cryptococcosis , 2000, Infection and Immunity.

[5]  T. Brandhorst,et al.  EVIDENCE FOR A NOVEL MECHANISM OF CELL SURFACE LOCALIZATION OF A VIRULENCE-ASSOCIATED ADHESIN VIA EXTRACELLULAR RELEASE AND REASSOCIATION WITH CELL WALL CHITIN* , 2000 .

[6]  B. Wanke,et al.  Possible primary ecological niche of Cryptococcus neoformans. , 2000, Medical mycology.

[7]  P. Williamson,et al.  Laccase Protects Cryptococcus neoformansfrom Antifungal Activity of Alveolar Macrophages , 1999, Infection and Immunity.

[8]  W. Tanner,et al.  Role of NaOH‐extractable cell wall proteins Ccw5p, Ccw6p, Ccw7p and Ccw8p (members of the Pir protein family) in stability of the Saccharomyces cerevisiae cell wall , 1999, Yeast.

[9]  T. Harrison,et al.  Cryptococcus neoformans Resides in an Acidic Phagolysosome of Human Macrophages , 1999, Infection and Immunity.

[10]  K. Wakamatsu,et al.  Catecholamine Oxidative Products, but Not Melanin, Are Produced by Cryptococcus neoformans during Neuropathogenesis in Mice , 1999, Infection and Immunity.

[11]  K. Wakamatsu,et al.  Melanin Biosynthesis in Cryptococcus neoformans , 1998, Journal of bacteriology.

[12]  E. Hudson,et al.  Development and applications of enhanced green fluorescent protein mutants. , 1998, BioTechniques.

[13]  A. Casadevall,et al.  Melanization of Cryptococcus neoformans in Murine Infection , 1998 .

[14]  B. Reinhold,et al.  Architecture of the Yeast Cell Wall , 1997, The Journal of Biological Chemistry.

[15]  J. Heitman,et al.  Calcineurin is required for virulence of Cryptococcus neoformans , 1997, The EMBO journal.

[16]  T. Sorrell,et al.  Phospholipase activity in Cryptococcus neoformans: a new virulence factor? , 1997, The Journal of infectious diseases.

[17]  E. Jacobson,et al.  Ferric iron reduction by Cryptococcus neoformans , 1997, Infection and immunity.

[18]  J. Perfect,et al.  Dominant selection system for use in Cryptococcus neoformans. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[19]  A. Casadevall,et al.  Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans , 1996, Infection and immunity.

[20]  J. Kaplan,et al.  Molecular biology of iron acquisition in Saccharomyces cerevisiae , 1996, Molecular microbiology.

[21]  B. Wong,et al.  Stress tolerance and pathogenic potential of a mannitol mutant of Cryptococcus neoformans. , 1996, Microbiology.

[22]  L. Frontali,et al.  The ‘petite‐negative’ yeast Kluyveromyces lactis has a single gene expressing pyruvate decarboxylase activity , 1996, Molecular microbiology.

[23]  R. Wiesner,et al.  Concentrations of 3,4‐Dihydroxyphenylalanine and Catecholamines and Metabolites in Brain in an Anhepatic Model of Hepatic Encephalopathy , 1995, Journal of neurochemistry.

[24]  R. Pinner,et al.  Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  A. Casadevall,et al.  Virulence: Mechanism of Action. Cryptococcus Neoformans Melanin And , 1995 .

[26]  K. Kwon-Chung,et al.  Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence , 1994, Molecular and cellular biology.

[27]  P. Williamson Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase , 1994, Journal of bacteriology.

[28]  T. Morita,et al.  Characterization of a Phenol Oxidase from Cryptococcus neoformans var. neoformans , 1993, Microbiology and immunology.

[29]  K. Kwon-Chung,et al.  Rapid method to extract DNA from Cryptococcus neoformans , 1991, Journal of clinical microbiology.

[30]  D Botstein,et al.  Suppressors of yeast actin mutations. , 1989, Genetics.

[31]  S. Emr,et al.  Organelle assembly in yeast: characterization of yeast mutants defective in vacuolar biogenesis and protein sorting , 1988, The Journal of cell biology.

[32]  T. Kozel,et al.  Role of the capsule in phagocytosis of Cryptococcus neoformans. , 1988, Reviews of infectious diseases.

[33]  T. Umezawa,et al.  Degradation mechanisms of phenolic beta-1 lignin substructure model compounds by laccase of Coriolus versicolor. , 1988, Archives of biochemistry and biophysics.

[34]  V. Hearing,et al.  Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans , 1982, Journal of bacteriology.

[35]  D. Scheidegger,et al.  Production of monoclonal antibodies: strategy and tactics. , 1980, Journal of immunological methods.

[36]  D. Tse,et al.  Potential oxidative pathways of brain catecholamines. , 1976, Journal of medicinal chemistry.

[37]  R. Tyndall,et al.  Pigment production by Cryptococcus neoformans from para- and ortho-Diphenols: effect of the nitrogen source , 1975, Journal of clinical microbiology.

[38]  F. Smith,et al.  COLORIMETRIC METHOD FOR DETER-MINATION OF SUGAR AND RELATED SUBSTANCE , 1956 .

[39]  A. L. Houwink,et al.  Composition and Structure of Yeast Cell Walls , 1951, Nature.